Tumor necrosis factor receptor-1 is critically involved in the development of experimental autoimmune myasthenia gravis

Author： Wang H-B.  

Publisher： Oxford University Press

ISSN： 1460-2377

Source： International Immunology, Vol.12, Iss.10, 2000-10, pp. : 1381-1388

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Effect of B Cell Deficiency on the Immune Response to Acetylcholine Receptor and the Development of Experimental Autoimmune Myasthenia Gravis

By Dedhia V.   Goluszko E.   Wu B.   Deng C.   Christadoss P.  

Clinical Immunology, Vol. 87, Iss. 3, 1998-06 ,pp. : 266-275

Academic Press

Access to resources Recommend Favorite

Anti-TNF-α Antibodies Suppress the Development of Experimental Autoimmune Myasthenia Gravis

By Duan R-S.   Wang H-B.   Yang J-S.   Scallon B.   Link H.   Xiao B-G.  

Journal of Autoimmunity, Vol. 19, Iss. 4, 2002-12 ,pp. : 169-174

Academic Press

Access to resources Recommend Favorite

Breakage of tolerance to hidden cytoplasmic epitopes of the acetylcholine receptor in experimental autoimmune myasthenia gravis

By Feferman T.   Im S.-H.   Fuchs S.   Souroujon M.C.  

Journal of Neuroimmunology, Vol. 140, Iss. 1, 2003-07 ,pp. : 153-158

Elsevier

Access to resources Recommend Favorite

A hierarchy of T cell receptor motifs determines responsiveness to the immunodominant epitope in experimental autoimmune myasthenia gravis

By Standifer N.E.   Kraig E.   Infante A.J.  

Journal of Neuroimmunology, Vol. 145, Iss. 1, 2003-12 ,pp. : 68-76

Elsevier

Access to resources Recommend Favorite

Autoimmune kidney disease and lymphadenopathy in NOD lpr mice are not modified by deficiency in tumor necrosis factor receptor 1 or  2 -microglobulin

By Catterall T.  

International Immunology, Vol. 15, Iss. 6, 2003-06 ,pp. : 679-690

Oxford University Press

Access to resources Recommend Favorite